Six months after consolidating a number of customer-facing functions under
its first vice president of customer success, Microfluidics
has completed the first phase of its transition to a more customer-centric organization.
In addition, the worldwide provider of high shear fluid processors has deepened
its domain expertise by hiring a senior marketing manager with biopharmaceutical
Microfluidics' unique organizational structure unites product management, marketing,
customer support and a parts and services business unit under Mary Anne North,
Vice President of Customer Success, in order to ensure the success of Microfluidics'
customers around the globe and across their entire experience with the Company.
With that objective, the Company's early customer success initiatives
- Appointing Dave Gucwa as Product Manager, to benefit end users by capitalizing
on his customer, application and product insights developed through 20 years
in sales and technical roles at Microfluidics
- Launching new process consulting and advisory services and preventive maintenance
contracts, to help customers innovate by sharing technology and process expertise
and ensure their successful ongoing use of Microfluidizer® processors
- Beginning a university program, to further serve a constituency with which
it has worked closely since the Company's founding
- Expanding its customer support team, surveying customers, and increasing
“Microfluidics continues to build a culture and a company where the customer
is always the focus,” noted Ms. North. “Microfluidics succeeds by
ensuring that our customers succeed, through developing innovative products
and services that meet their evolving needs and fully supporting their use of
Kris Sarajian recently joined Microfluidics' customer success team as
Senior Marketing Manager, after marketing roles at PHT Corporation and information
technology infrastructure provider Akibia. PHT is a fast-growth market-leading
provider of electronic patient reported outcome (ePRO) solutions used by biopharmaceutical
and medical device companies in clinical trials around the world. Although Mr.
Sarajian will help Microfluidics to better communicate with its customers across
all industries, his biopharmaceutical industry knowledge in particular helps
Microfluidics to support its extensive customer base in those industries.
“Given its strong industry reputation, enormous installed base of more
than 3,000 units worldwide, and redoubled emphasis on customer success, the
decision to join Microfluidics was an easy and exciting one,” said Mr.
Sarajian. “I look forward to working with the dedicated Customer Success
team to share stories of how forward-thinking companies in the biopharmaceutical
and other industries are using exclusive Microfluidics technology to innovate
new products, develop novel therapies and improve quality of life.”